Procedure Guideline for Scintigraphic Imaging in Cardiac Transthyretin Amyloidosis

[ X ]

Tarih

2024

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Galenos Publishing House

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Amyloidosis is a systemic disorder characterized by the extracellular deposition of amyloid fibrils in various tissues, with the potential for cardiac involvement. Cardiac amyloidosis, a relatively uncommon and frequently underdiagnosed etiology of heart failure, can manifest due to the infiltration of several amyloid types into the myocardium. The definitive diagnosis typically involves an endomyocardial biopsy. Utilizing scintigraphic imaging with Technetium-99m (Tc-99m) labeled bisphosphonates can aid in the early identification of cardiac involvement and differentiate between different forms of cardiac amyloidosis. This guideline aims to support nuclear medicine practitioners in advising, performing imaging procedures, documenting findings, and interpreting results from scintigraphy involving Tc-99mlabeled bone radiopharmaceuticals for the assessment of transthyretin cardiac amyloidosis. © 2024 Galenos Publishing House. All rights reserved.

Açıklama

Anahtar Kelimeler

Cardiac amyloidosis, scintigraphy, SPECT, SPECT/CT

Kaynak

Nuclear Medicine Seminars

WoS Q Değeri

Scopus Q Değeri

Q4

Cilt

10

Sayı

1

Künye